Winning the EIC Accelerator once is hard. Winning it twice is a craft

Anyone who has gone through the EIC Accelerator process knows how demanding it is. Months of preparation. Relentless scrutiny. A success rate in the low single digits.
So what does it take to secure EIC support not once, but twice?

Cellevate, one of GAEU’s long-term biotech clients, has now entered negotiations for a potential equity investment from the EIC Fund, following a highly competitive selection process. This marks the second time the company has successfully navigated the EIC Accelerator framework.

And contrary to what some might assume, the second time is not easier.
When a company returns to the EIC, the bar is higher. Evaluators look closely at actual progress delivered, milestones achieved, strategic execution, market validation, etc. At the same time, the competition evolves. New technologies emerge. Standards rise. Success at this level is never automatic. It is earned - again.

At GAEU, we are proud to have supported Cellevate throughout this journey. Not just in preparing an application, but in shaping strategy, aligning milestones, structuring positioning, and navigating one of Europe’s most rigorous funding processes. EIC Accelerator outcomes are never guaranteed. Markets evolve. Technologies mature at different speeds. Companies face complex realities.

But what remains constant is the craft required to compete - and win - at the highest European innovation level. Securing EIC Accelerator support twice reflects disciplined execution, resilience, and the ability to withstand deep technical and commercial due diligence. This is what long-term collaboration looks like. And this is the standard we hold ourselves to at GAEU. Thank you Cellevate for your trust in us!

Please read Cellevate’s press release here: https://cellevate.com/cellevate-selected-to-enter-negotiations-for-equity-investment-from-eic-fund/